This inventor holds 1 USPTO granted patent. Top assignee: Immunex Corporation. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Barry L. Davison: Innovator in Immunology
Introduction
Barry L. Davison is a notable inventor based in Mercer Island, WA (US). He has made significant contributions to the field of immunology, particularly through his innovative research and patent work. His expertise has led to advancements that could impact therapeutic approaches in immunological disorders.
Latest Patents
Barry L. Davison holds a patent for "Defective CD4+ T-cells that express active CD40-L." This patent describes CD4 cells obtained from individuals with a defective CD40L gene, which are transfected with a vector containing CD40-L. This innovation has the potential to enhance our understanding of immune responses and therapeutic strategies.
Career Highlights
Throughout his career, Barry has been associated with Immunex Corporation, where he has contributed to various research initiatives. His work has focused on the intersection of genetics and immunology, leading to breakthroughs that could improve patient outcomes in immunological therapies.
Collaborations
Barry has collaborated with esteemed colleagues, including Melanie K. Spriggs and Richard Jeffrey Armitage. These partnerships have fostered a collaborative environment that encourages innovative research and development in the field.
Conclusion
In summary, Barry L. Davison is a distinguished inventor whose work in immunology has led to valuable patents and collaborations. His contributions continue to shape the landscape of immunological research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile